PLX SG&A Expense Growth
Protalix Biotherapeutics Inc · SG&A Expense Growth
PLX SG&A Expense Growth
Latest reported-4.19%period ending
PLX FY SG&A Growth (YoY) (0.00% → -4.19%)
Latest values, visible window
High-resolution chart · PNG
PLX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -4.1909% | |
| -18.4905% | |
| 27.7346% | |
| -7.9975% | |
| 14.1819% | |
| 12.6174% | |
| -9.3166% | |
| -5.3252% | |
| 23.2364% | |
| 28.5341% | |
| -21.1205% | |
| 10.0537% | |
| -14.1145% | |
| 40.8599% | |
| 0.7999% | |
| -3.7514% | |
| 5.5244% | |
| -42.1664% | |
| 158.6961% | |
| 4,750.2063% | |
| -88.4393% | |
| 447.5455% | |
| -11.1014% | |
| -43.1815% | |
| -23.5858% | |
| -74.9441% | |
| -26.9415% | |
| 1,168.9954% | |
| 273.1036% | |
| 0% |